Impact of chronic stress on the HPA axis: neuroendocrine dysregulation and neurobiological markers in psychiatric disorders
Abstract
Background: The hypothalamic–pituitary–adrenal (HPA) axis has been widely associated with various psychiatric disorders due to its role in the stress response, primarily mediated by cortisol release. Scientific evidence indicates that alterations in these biomarkers are related to conditions such as post-traumatic stress disorder, depression, anxiety, and bipolar disorder. In this context, investigating these mechanisms is essential for understanding the neurobiological foundations of these disorders and for the early identification of neuroendocrine alterations associated with their progression. Objective: To analyze the relationship between chronic stress, HPA axis dysfunction, and neurobiological alterations associated with psychiatric disorders. Methods: This is a qualitative systematic literature review. The descriptors “hypothalamic–pituitary–adrenal axis,” “psychiatric disorders,” and “stress” were used in the SciELO and PubMed databases. The search included articles published between January 2021 and January 2026, in Portuguese, English, and Spanish. Initially, 20 studies were identified, of which 6 met the inclusion criteria and were selected for analysis. Results: Sustained hyperactivation of the HPA axis promotes increased cortisol levels and is associated with alterations in the plasticity and functioning of the prefrontal cortex, leading to impairment of executive control and emotional regulation. This process contributes to overload of the central nervous system and to mental exhaustion in contexts of chronic stress. Prolonged exposure to stressors may lead to sensitization of glucocorticoid receptors, intensifying axis dysregulation and its impact on limbic structures such as the amygdala and hippocampus, thereby favoring dysfunctional circuits related to hypervigilance and the rumination of traumatic memories. In the absence of adequate regulation, there is a greater tendency toward symptom progression and the development of psychiatric comorbidities. Conclusion: The interaction between neurology and psychiatry highlights that chronic stress is associated with measurable neurobiological alterations, particularly in the HPA axis. The assessment of neuroendocrine biomarkers emerges as a promising strategy for the early identification of central nervous system dysfunctions. Furthermore, this approach may contribute to preventive interventions and to the development of therapeutic strategies based on personalized medicine.